Experimental nanomedicine vaccine designed to combat Neuroblastoma

A team of academics lead by University of Maryland’s Christopher Jewell, professor of bioengineering, have been awarded a $375,000 grant this week to develop a vaccine to help combat neuroblastoma, the third most common pediatric cancer. The prototype vaccine tackles the cancer cells through stimulating the body’s own immune response. What Professor Jewel hopes will make this vaccine work more …